HK1197057A1 - 新的脂肪生成抑制劑化合物 - Google Patents

新的脂肪生成抑制劑化合物

Info

Publication number
HK1197057A1
HK1197057A1 HK14110259A HK14110259A HK1197057A1 HK 1197057 A1 HK1197057 A1 HK 1197057A1 HK 14110259 A HK14110259 A HK 14110259A HK 14110259 A HK14110259 A HK 14110259A HK 1197057 A1 HK1197057 A1 HK 1197057A1
Authority
HK
Hong Kong
Prior art keywords
inhibitor compounds
lipogenesis inhibitor
new
new lipogenesis
compounds
Prior art date
Application number
HK14110259A
Other languages
English (en)
Inventor
．勒杜萊斯
．多納斯-馬里奧
．普瓦尼
．加利亞諾
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197057A1 publication Critical patent/HK1197057A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)
HK14110259A 2011-12-08 2014-10-14 新的脂肪生成抑制劑化合物 HK1197057A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1161341A FR2983858B1 (fr) 2011-12-08 2011-12-08 Nouveaux composes inhibiteurs de la lipogenese
PCT/EP2012/074891 WO2013083825A1 (fr) 2011-12-08 2012-12-10 Nouveaux composes inhibiteurs de la lipogenese

Publications (1)

Publication Number Publication Date
HK1197057A1 true HK1197057A1 (zh) 2015-01-02

Family

ID=47324157

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110259A HK1197057A1 (zh) 2011-12-08 2014-10-14 新的脂肪生成抑制劑化合物

Country Status (13)

Country Link
US (1) US9181189B2 (zh)
EP (1) EP2788327A1 (zh)
JP (1) JP6113744B2 (zh)
KR (1) KR20140101834A (zh)
CN (1) CN103974937A (zh)
AU (1) AU2012350282A1 (zh)
BR (1) BR112014013719A2 (zh)
CA (1) CA2857973A1 (zh)
FR (1) FR2983858B1 (zh)
HK (1) HK1197057A1 (zh)
MX (1) MX2014006699A (zh)
RU (1) RU2014126394A (zh)
WO (1) WO2013083825A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130995A1 (it) * 2013-06-17 2014-12-18 Chemelectiva S R L Derivati dell'acido retinoico e processo per la loro preparazione
FR3020951B1 (fr) 2014-05-16 2016-06-17 Pierre Fabre Dermo-Cosmetique Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique.
FR3026011B1 (fr) * 2014-09-24 2019-07-19 Greenpharma Composition contenant au moins un inhibiteur de certaines chimiokines, son procede d'obtention et son utilisation dermocosmetique pharmaceutique
US11767314B2 (en) 2018-11-02 2023-09-26 Conopco, Inc. Bioenergetic nicotinic acid glycerol esters, compositions and methods of using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849576A (en) * 1964-01-29 1974-11-19 Oreal Process and cosmetic compositions for the treatment of skin and scalp
DE3534421A1 (de) 1985-09-27 1987-04-02 Bayer Ag Verwendung von thienylaminen als leistungsfoerdernde mittel, neues thienylamin
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5750108A (en) * 1995-09-18 1998-05-12 Regenix Marketing Systems, Inc. Hair treatment system and kit for invigorating hair growth
DE19639818A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
AU2002253441A1 (en) * 2002-04-12 2003-10-27 Silbiotec Due S.A. Medicaments containing glycerophosphoinositol-4-phosphate derivatives
US20040081672A1 (en) * 2002-10-25 2004-04-29 Gupta Shyam K. Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging
US7300957B1 (en) * 2006-06-16 2007-11-27 Whewell Christopher J Skin care compositions
US8143410B2 (en) 2006-11-16 2012-03-27 Allergan, Inc. Kinase inhibitors
EP2161290B1 (en) * 2008-09-09 2011-12-14 Agfa Graphics N.V. Radiation curable compositions
FR2940281B1 (fr) * 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
FR2954124B1 (fr) * 2009-12-18 2012-04-06 Fabre Pierre Dermo Cosmetique Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee

Also Published As

Publication number Publication date
US9181189B2 (en) 2015-11-10
CN103974937A (zh) 2014-08-06
KR20140101834A (ko) 2014-08-20
RU2014126394A (ru) 2016-01-27
BR112014013719A8 (pt) 2017-06-13
AU2012350282A1 (en) 2014-06-19
MX2014006699A (es) 2014-07-09
FR2983858A1 (fr) 2013-06-14
JP2015502950A (ja) 2015-01-29
US20140315950A1 (en) 2014-10-23
BR112014013719A2 (pt) 2017-06-13
JP6113744B2 (ja) 2017-04-12
WO2013083825A1 (fr) 2013-06-13
FR2983858B1 (fr) 2014-01-03
EP2788327A1 (fr) 2014-10-15
CA2857973A1 (fr) 2013-06-13

Similar Documents

Publication Publication Date Title
HK1257823A1 (zh) 金屬酶抑制劑化合物
HK1198163A1 (zh) 金屬酶抑制劑化合物
HK1198651A1 (zh) 金屬酶抑制劑化合物
HK1211921A1 (zh) 抑制劑化合物
EP2723731A4 (en) COMPOUNDS INHIBITING METALLOENZYMES
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
PT2710018T (pt) Compostos macrocíclicos como inibidores de proteína quinases
GB201118652D0 (en) New compounds
GB201118654D0 (en) New compounds
LT2776436T (lt) Naujieji junginiai
IL231352A0 (en) New enzyme inhibitory compounds
IL231353A0 (en) New enzyme inhibitory compounds
GB201106814D0 (en) New compounds
HK1197057A1 (zh) 新的脂肪生成抑制劑化合物
EP2771012A4 (en) NEW CONNECTIONS
EP2751117A4 (en) METALLOENZYMHEMMERVERBINDUNGEN
GB201211019D0 (en) Inhibitor compounds
HK1191946A1 (zh) 新型六氫吡咯並咪唑酮化合物
GB201004308D0 (en) New inhibitor compounds
GB201108188D0 (en) Corrosion inhibitor
GB201119590D0 (en) New compounds I
GB201120474D0 (en) Inhibitors